NMN vs NR: what's the difference?

Updated November 3, 2026. For information only, not medical advice. This guide has no affiliate links.

In a nutshell

• NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are two “precursors” that the body can turn into NAD+, a molecule every cell uses.
• The only head-to-head human trial we found compared them for 14 days. Both raised blood NAD+ by a similar amount.
• Nobody has compared them over months or years for health outcomes. Trials of each one so far have mostly not shown clear benefits for how people feel or function.
• So the honest answer to “which is better, NMN or NR?” is: we do not know yet. Evidence rating for either one improving health: Early.

Availability varies by country; check local rules before buying. In the US, the FDA wrote in a letter: “we now conclude that NMN is not excluded from the definition of dietary supplement under section 201(ff)(3)(B)” (FDA letter of Sept 29, 2025); that is not an FDA approval. Related guides: is NMN FDA approved? and is NMN legal in the US? We do not link to NMN products.

What are NMN and NR?

Both are related to vitamin B3, and both are used by the body to make NAD+. Our explainer on NAD+ covers what that molecule does. A 2026 study in Nature Metabolism calls nicotinamide (another B3 form), NR and NMN the most prominent NAD+ “boosters”.

In short, they are different starting ingredients for the same end product (NAD+). Neither one is the same thing as NAD+ itself, which some clinics give by injection or drip (see our guide to NAD+ injections). They have also been tested in different trials, on different people, at different doses, which makes them hard to compare.

Which one raises NAD+ more?

Basis: PMID 41540253 (Christen et al., Nat Metab 2026).

The best direct comparison is the 2026 Nature Metabolism study. It was a randomized, open-label, placebo-controlled trial in 65 healthy adults over 14 days (abstract; doses from the full paper). Groups took 1,000 mg a day of NR, 1,000 mg a day of NMN, 500 mg a day of nicotinamide, or placebo.

The result: NR and NMN, but not nicotinamide, “comparably” raised circulating NAD+. In other words, neither beat the other on that measure.

Three cautions. It lasted only two weeks. It measured NAD+ in the blood, not health outcomes. And most of the authors are employees of Nestlé, which is disclosed in the paper.

What do human trials show for NMN?

Basis: PMIDs 33888596, 35927255, 36482258, 38789831 and the npj Aging 2026 trial (DOI 10.1038/s41514-026-00482-7).

• Blood NAD+ goes up. In a 10-week trial, 25 postmenopausal women with prediabetes who were overweight or obese (13 on NMN, 12 on placebo) took 250 mg a day (full text). Muscle insulin sensitivity improved. Other measures, including fasting blood sugar, were not affected.
• Older men. A 2022 trial in healthy older men gave 250 mg a day for 6 or 12 weeks. Blood NAD+ rose. Gait speed and performance in the left-hand grip test showed “nominally significant” improvements, which the authors said should be validated in larger studies. Body composition did not change significantly. Three authors are employees of Mitsubishi Corporation Life Sciences Limited.
• Healthy middle-aged adults, several doses. A 60-day trial gave 80 adults 300, 600 or 900 mg a day or placebo. Blood NAD rose in every NMN group, and the authors reported no safety issues. Three authors are employees of Abinopharm and Aba Chemicals, per the paper’s disclosures.
• Older adults, 12 weeks. A Japanese trial gave 60 older adults 250 mg a day. On its main measure (a stepping test) NMN and placebo did not differ significantly. On secondary measures, 4-meter walking time and sleep-questionnaire scores were better in the NMN group. Three authors are employees of Meiji Holding.
• Higher dose, longer. A 2026 trial in adults aged 65 and over used 1,250 mg a day for 24 weeks. Blood NAD+ rose, but there was no significant improvement in hearing (the main outcome) or in physical performance. The company that makes the NMN funded the trial and supplied it, and three authors are its employees. See our news report.

What do human trials show for NR?

Basis: PMIDs 29599478, 31278280, 37994989, 42848371.

• Blood NAD+ goes up. In a crossover trial, 24 healthy middle-aged and older adults took 1,000 mg a day for two 6-week periods (one on NR, one on placebo). NAD+ in blood cells was about 60% higher on NR, according to the full paper. The authors said blood pressure and artery stiffness deserve further study, but that was an exploratory finding.
• Safety over 8 weeks. In an 8-week trial of overweight adults, 100, 300 and 1,000 mg a day raised whole-blood NAD+ in a dose-related way, with no significant difference in adverse events from placebo. The study was funded by ChromaDex, and two authors are its employees.
• Older adults with mild cognitive impairment. In a small 10-week trial, 20 people took up to 1 g a day. Blood NAD+ rose 2.6-fold and cognition test scores stayed stable. The authors called for a larger trial. NR and placebo were supplied by ChromaDex, and one co-author is its chief scientific adviser.
• A large trial in Parkinson’s disease. The NOPARK trial randomized 410 people with early Parkinson’s to 500 mg of NR twice a day or placebo for 52 weeks. The NR group’s main symptom score was 2.72 points worse than placebo (on a 0 to 236 scale). The authors concluded the findings do not support NR as a disease-modifying treatment. Serious adverse events were reported in 8.3% of the NR group and 14.1% of the placebo group. This was a trial in people with a specific condition, so it cannot tell us what NR does in healthy adults. See our news report.

What about muscle and fitness?

Basis: PMID 40275690 (Prokopidis et al., J Cachexia Sarcopenia Muscle 2025).

A 2025 meta-analysis pooled randomized trials of NMN or NR against placebo in adults with an average age over 60. NMN had no significant effect on muscle index, grip strength, gait speed or chair-stand time. The authors concluded that current evidence “does not support” either supplement for preserving muscle mass and function in this age group. They added that future research should look at dose and at people who start with low NAD+.

How do NMN and NR compare at a glance?

Basis: the trials in the sections above.

	NMN	NR
What it is	A precursor the body can turn into NAD+	A form of vitamin B3 the body can turn into NAD+
Raises blood NAD+ in humans?	Yes, in several small trials	Yes, in several small trials
Head-to-head result	Similar to NR over 14 days	Similar to NMN over 14 days
Clear health benefit shown?	Not yet. Mixed or neutral results	Not yet. Mixed or neutral results
Longest trial we cite	24 weeks (1,250 mg a day)	52 weeks (1,000 mg a day, in Parkinson’s)
Evidence rating	Early	Early

Is one safer than the other?

Basis: PMIDs 42514320, 31278280; EFSA opinion, PMID 42125559.

In the short trials we read, both were reported as generally well tolerated. A 2026 meta-analysis of 15 randomized trials of oral NMN (10 contributed to safety analyses; doses 250 to 2,000 mg a day, 14 days to 24 weeks) found no increase in overall, serious or system-specific adverse events, and no significant rise in liver enzymes. It stressed that the evidence is short-term and that larger, longer trials are needed. For NR, the 8-week trial above found adverse events no different from placebo.

EFSA, the EU’s food safety agency, concluded in 2026 that NMN is safe up to 300 mg a day for adults, excluding pregnant and lactating women (EFSA opinion). That is a safety assessment, not a trial, and it is lower than some doses used in trials.

Nobody has compared safety head to head over the long term, so we cannot say one is safer. Speak to a doctor or pharmacist first if you take medication or have a health condition, and ask before using either one if you are pregnant or breastfeeding.

So which is better, NMN or NR?

On the evidence we have, neither can claim to be better. They raised blood NAD+ by a similar amount in the one direct comparison. Neither has a track record of clear benefits in healthy adults, and the strongest “anti-aging” findings for both come from animals, not people. Online debates, including NMN vs NR Reddit threads, are anecdotes, not controlled trials.

Our best-of pages cover NR, not NMN: see the best NR supplement and best NAD+ supplement pages. That is a site decision, not a finding that NR works better. Best-of pages may carry affiliate links, with a disclosure above the first link (affiliate disclosure).

If you are curious, our beginner’s guides to NMN and NR go into each in more detail, what is NAD+ explains the molecule, how to choose an NMN supplement covers labels and dose (information only), and our guide to longevity supplements for beginners shows where they sit next to better-studied options.

FAQ

Which is better, NMN or NR?

Neither has been shown to be better. In the one head-to-head trial we found (65 healthy adults, 14 days, open-label), NMN and NR raised circulating NAD+ by a similar amount. Neither has clear health benefits in healthy adults in the trials we cite. We do not know which is better over months or years.

Basis: US Google autocomplete, Nov 3, 2026 (“which is better nmn or nr”, “nmn vs nr which is better”); PMIDs 41540253, 40275690.

Does David Sinclair take NMN or NR?

In a July 14, 2019 post on his own website, David Sinclair wrote, “It’s no secret that I take NMN.” In the same post he wrote that he has “absolutely no opinion whatsoever on whether anyone else should take these supplements” and that he does not sell supplements. The post does not say whether he also takes NR, and it may be out of date. One person’s routine is not evidence for what works for you.

Basis: US Google autocomplete, Nov 3, 2026 (“does david sinclair take nmn or nr”); David A. Sinclair, “Let’s talk about NMN and NR”, lifespanbook.com, July 14, 2019 (opened Nov 3, 2026).

What is the difference between NMN, NR and NAD+?

NAD+ is the molecule your cells use. NMN and NR are precursors the body can turn into NAD+, so “is NMN better than NAD+?” compares a building block with the finished molecule. In a 14-day trial of 65 adults, NMN and NR each raised blood NAD+. A 2026 systematic review found no outcome trials of IV or intramuscular NAD+ for anti-aging or wellness. See our guide to NAD+ injections.

Basis: US Google autocomplete, Nov 3, 2026 (“nmn vs nr vs nad”, “is nmn better than nad”); PMIDs 41540253, 41655607.

NMN vs NR vs niacin: what is the difference?

Niacin is vitamin B3. NIH says the name covers nicotinic acid, nicotinamide (niacinamide) and related forms such as nicotinamide riboside, and that the body converts niacin into NAD. High-dose nicotinic acid can cause skin flushing; nicotinamide does not. In a 14-day trial, NR and NMN at 1 g a day raised blood NAD+, but nicotinamide at 500 mg a day did not.

Basis: US Google autocomplete, Nov 3, 2026 (“nmn vs nr vs niacin”); NIH ODS niacin fact sheet for health professionals (updated November 18, 2022; opened Nov 3, 2026); PMID 41540253.

Can you take NMN and NR together?

We found no human trial that gave NMN and NR together. The 2026 head-to-head trial gave them in separate groups, and our PubMed check on November 3, 2026 found no combination trial. So we cannot say whether combining them adds anything or is safe. This is not advice either way. If you take medicines, ask a doctor or pharmacist.

Basis: US Google autocomplete, Nov 3, 2026 (“can you take nmn and nr together”); PMID 41540253 (separate arms); PubMed search, Nov 3, 2026.

What this means for you

What this means for you

• They do the same job: NMN and NR are two routes to the same molecule, NAD+, and raised blood levels by a similar amount over 14 days.
• Higher NAD+ is not the same as better health: in the human trials we read, improvements in hearing, strength or walking were not clearly shown.
• Doses studied: 250 mg to 1,250 mg a day for NMN (up to 900 mg in one 60-day trial), and 100 to 1,000 mg a day for NR (500 mg twice a day in NOPARK). These describe the studies, not advice.
• Who was studied: mostly small groups of healthy adults, women with prediabetes, older adults, or (for NOPARK) people with early Parkinson’s.
• Evidence rating: raising blood NAD+ in humans: Good. Improving health or function in humans: Early. Anti-aging results in animals: Very early (animal research only).

Sources

Pages were opened on November 1, 2026, unless a different date is given.

1. Christen S et al. The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans. Nat Metab 2026. PubMed · full text
2. Yoshino M et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science 2021. PubMed · PMC full text
3. Igarashi M et al. Chronic nicotinamide mononucleotide supplementation elevates blood NAD levels and alters muscle function in healthy older men. npj Aging 2022. PubMed
4. Sustained NAD+ augmentation by high-dose nicotinamide mononucleotide supplementation in older adults: a 24-week randomized, double-blind, placebo-controlled trial. npj Aging, September 25, 2026. DOI
5. Martens CR et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun 2018. PubMed · full text
6. Brakedal B et al. Nicotinamide riboside for patients with early-stage Parkinson disease: the NOPARK randomized clinical trial. JAMA, October 8, 2026. PubMed
7. Prokopidis K et al. The effect of nicotinamide mononucleotide and riboside on skeletal muscle mass and function: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 2025. PubMed
8. US Food and Drug Administration. Response to citizen petition, Docket FDA-2023-P-0872, on the status of NMN (the letter is dated September 29, 2025; the PDF header misprints the year as 2029; opened November 3, 2026).
9. Yi L et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults. GeroScience 2023. PubMed
10. Morifuji M et al. Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults. GeroScience 2024. PubMed
11. Conze D et al. Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. Sci Rep 2019. PubMed
12. Orr ME et al. A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment. GeroScience 2024. PubMed
13. Yang W et al. Safety and metabolism-related outcomes of oral nicotinamide mononucleotide supplementation in adults: a systematic review and meta-analysis. Nutrients, July 10, 2026. PubMed
14. Turck D et al. Safety of beta-nicotinamide mononucleotide (β-NMN) pursuant to Regulation (EU) 2015/2283 (EFSA NDA Panel). EFSA Journal, May 2026. PubMed
15. Gallagher C, Emmanuel OO. NAD⁺ supplementation for anti-aging and wellness: a PRISMA-guided systematic review. Ageing Res Rev, April 2026. PubMed (cited in the FAQ).
16. NIH Office of Dietary Supplements (US). Niacin: Fact Sheet for Health Professionals (updated November 18, 2022; opened November 3, 2026).
17. Sinclair DA. Let’s talk about NMN and NR, lifespanbook.com, July 14, 2019 (his own website; opened November 3, 2026).

This article is for information only and is not medical advice. Speak to a healthcare professional before changing medication or supplements.